Home › Funds › B Group, Inc. › TSHA

B Group, Inc. position in TSHA

TAYSHA GENE THERAPIES INC · Health Care

B Group, Inc. reported holding 1,800,556 shares of TSHA (TAYSHA GENE THERAPIES INC) in its Q2 2026 13F filing — a position valued at US$12.3M, representing 5.76% of its reported portfolio and ranking #6 among its reported holdings. B Group, Inc. has disclosed TSHA holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)1.80M sh
Reported value held$12.26M
Portfolio Weight5.76%
First reportedQ4 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How B Group, Inc.'s TSHA position evolved

B Group, Inc. first disclosed a stake in TSHA in Q4 2024 at 965,556 shares (US$1.7M). The position peaked in Q2 2026 at 1,800,556 shares, worth US$12.3M. Across 7 filings, B Group, Inc. increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 1,800,556 shares valued at US$12.3M. Notable position changes include a 30% increase in Q1 2025 (shares rose 66% over the following quarter), a 43% increase in Q2 2025 (shares rose 42% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 965.56K $1.67M New
Q1 2025 1.26M $1.75M Add
Q2 2025 1.80M $4.16M Add
Q3 2025 1.80M $5.89M Hold
Q4 2025 1.80M $9.90M Hold
Q1 2026 1.80M $8.05M Hold
Q2 2026 1.80M $12.26M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TSHA and 13F data

TSHA (TAYSHA GENE THERAPIES INC) is a Health Care company. 56 other funds we track also report a position in TSHA — the largest reported positions include Avoro Capital Advisors LLC (US$162.7M), RA CAPITAL MANAGEMENT, L.P. (US$160.4M), Vestal Point Capital, LP (US$132.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TSHA

All TSHA fund holders →

FAQ

How long has B Group, Inc. held TSHA?

B Group, Inc. has disclosed TSHA holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is B Group, Inc.'s current position in TSHA?

As of Q2 2026, B Group, Inc. holds 1.80M shares of TSHA (TAYSHA GENE THERAPIES INC), valued at $12.26M, representing 5.76% of its reported portfolio and ranking #6.

Has B Group, Inc. been buying or selling TSHA?

In the latest 13F filing (Q2 2026), B Group, Inc. held unchanged its position in TSHA. The position peaked in Q2 2026 at 1.80M shares.

Which other funds hold TSHA?

Other major institutional holders of TSHA include Avoro Capital Advisors LLC, RA CAPITAL MANAGEMENT, L.P., Vestal Point Capital, LP, among 56 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.